Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Maria Arnaiz

Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Cover Picture: Protic and Aprotic Ionic Liquids in Combination With Hard Carbon for Lithium-Ion and Sodium-Ion Batteries

Batteries & Supercaps
2018English

Related publications

Is the PTV Margin Important for Local Control in Stage I Non-Small Cell Lung Cancer (NSCLC) Patients Treated With Definitive SBRT?

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

OA06.05 Do SBRT Planning and Delivery Factors Influence Local Control for Early Stage Non-Small Cell Lung Cancer (E-Nsclc)?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

SBRT for Early-Stage Glottic Larynx Cancer—Initial Clinical Outcomes From a Phase I Clinical Trial

PLoS ONE
Multidisciplinary
2017English

Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated After Chemoradiotherapy and an 8-Year Update on a Phase I/Ii Trial

Clinical Cancer Research
Cancer ResearchOncology
2011English

SBRT for Central Tumors in Early Stage NSCLC Patients

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

P3.17-12 Phase II Trial of Atezolizumab Before and After Chemoradiation for Unresectable Stage III NSCLC (AFT-16): Trial in Progress

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

SBRT Effective for Inoperable Early-Stage Lung Cancer

Cancer Discovery
Oncology
2014English

640. AdCD40L Immunostimulatory Gene Therapy in Combination With Cyclophosphamide Prolongs 6-Months Survival in a Phase I/Ii Trial for Malignant Melanoma

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

P1.01-47 Phase I/Ii Trial of Dasatinib and Osimertinib in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy